Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6208 of 6351
-
Cystic fibrosis drug combo put to the test with statins
Knowledge-focused CompletedThe purpose of this study is to evaluate the effect of multiple doses of vanzacaftor/tezacaftor/deutivacaftor (VNZ/TEZ/D-IVA) on the PK of rosuvastatin and the safety and tolerability of coadministration of VNZ/TEZ/D-IVA with rosuvastatin.
Phase 1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Fruit stands vs. fruit stands plus campaign: which gets kids eating more?
Knowledge-focused Recruiting nowThis implementation study evaluates two strategies to increase fruit consumption among Swedish students. (1) installing fruit stands in schools and (2) combining fruit stands with a health-awareness campaign. The intervention is implemented in a set of participating schools, each…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Healthy volunteers help test how a new drug enters the blood
Knowledge-focused CompletedThe purpose of this study is to find out how much LY4064809 gets into the blood stream and how long it takes the body to get rid of it when it is given as two formulations. For each participant, the study will last about nine weeks. Participants will remain in the clinical resear…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New drug SYH2085 tested in healthy people for first time
Knowledge-focused Recruiting nowRandomized, double-blind and placebo-controlled study to assess the safety, tolerability and pharmacokinetics of single ascending doses of SYH2085 and its food effect in China healthy adult participants. The study is composed of 2 parts. Part 1 is to assess the safety, tolerabili…
Phase 1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Parent perceptions linked to toddler motor skills in new study
Knowledge-focused OngoingThis study aims to determine motor competence and physical activity levels in children aged 4-6 years and to explore their relationship with parental perceptions. The study will use a qualitative research approach supported by quantitative assessments. Children's motor competence…
Sponsor: Pamukkale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Doctors reveal why they ignore helpful computer tools in the ER
Knowledge-focused CompletedA Qualitative Study to Explore the Barriers to Adoption of Clinical Decision Support Systems
Sponsor: Medway NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Healthy volunteers needed to test new fatty liver drug with and without food
Knowledge-focused Recruiting nowThis is a Phase I, open-label, randomized, single-dose, 2-part study designed to evaluate the food effect and relative bioavailability of ECC4703 in healthy adult participants.
Phase 1 • Sponsor: Eccogene • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Healthy men needed to check if updated obesity drug matches original
Knowledge-focused Recruiting nowThis is an open-label, randomized, single-dose, parallel comparison bioequivalence study conducted in healthy adult male subjects. The study is divided into 3 parts, each of which evaluates the bioequivalence of GZR18 Injection for one strength before and after CMC changes. Sub…
Phase 1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New triple diabetes pill tested in healthy adults
Knowledge-focused CompletedBioequivalence study for the fixed-dose combination of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg under fasting conditions in healthy volunteers
Phase 1 • Sponsor: LG Chem • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Jaw surgery tool tested for cleaner breaks
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate if use of an inferior border saw while making the inferior border osteotomy is associated with the medial cortex fracture pattern.
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New drug GS3-007a tested for safety in healthy volunteers
Knowledge-focused Recruiting nowThis study consists of two parts: the first part is a single-dose escalating(SAD) and food effect (FE)study, and the second part is a multiple-dose (14-day) escalating(MAD) study. Both phases are designed as randomized, double-blind, dose-escalation, placebo-controlled clinical s…
Phase 1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Early study checks how new drug DA-1229_01 behaves in the body
Knowledge-focused CompletedThis clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 at fed state.
Phase 1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Bipolar depression study scrapped before it began
Knowledge-focused CancelledBipolar disorder is a common condition that can cause significant disability and risk for suicide. Second generation antipsychotic medications can be used to treat depression in bipolar disorder, yet we do not know how they work. Here, we will use a recently approved medication, …
Phase 4 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Knee infection antibiotic study pulled before starting
Knowledge-focused CancelledPatients presenting with prosthetic joint infections of a total knee replacement who are treated with an antibiotic spacer will be observed prospectively for their response to treatment and antibiotic elution profiles will be measured post-operatively utilizing mass spectrometry …
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
UCLA tests text reminders to cure chronic lateness
Knowledge-focused Recruiting nowThis is a prospective clinical trial evaluating how behaviorally informed message framing can improve patient on-time arrival for outpatient visits. This trial is being implemented in conjunction with UCLA Health's broader operational quality improvement (QI) efforts to enhance c…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Healthy volunteers needed to test how common drugs interact with experimental medicine
Knowledge-focused Recruiting nowThis study is an open-label, fixed-sequence, two-period Phase 1 clinical trial in healthy adult Chinese participants with a total of 3 cohorts, 16-20 healthy adult Chinese participants are planned to be enrolled in each cohort.
Phase 1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New drug VV261 tested in healthy people for first time
Knowledge-focused Recruiting nowThis is a randomized, double-blind, placebo-controlled, single ascending-dose study to evaluate the safety, tolerability and pharmacokinetics characteristics of VV261 tablets in healthy adults.
Phase 1 • Sponsor: Vigonvita Life Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Healthy volunteers needed to test drug interaction
Knowledge-focused Not yet recruitingA drug-drug interaction study designed to evaluate the drug-drug interaction between rifampin capsules and anaprazole sodium enteric-coated tablets in healthy adult subjects
Phase 4 • Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Stem cell therapy for COVID-19 lung damage trial pulled before it began
Disease control CancelledAllogeneic culture-expanded bone marrow-derived human mesenchymal stem cells (MSC) are the subject of the current study as they are supported by preclinical and clinical data for potential to provide a safe and effective treatment for patients with acute respiratory distress.
Phase 1 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Healthy men test two versions of TJ101 injection for similarity
Knowledge-focused CompletedThis is Single-center, randomized, open-label, single-dose, two-period crossover study design. The goal is to preliminary evaluate the PK comparability of TJ101 injection before and after CMC change following a single subcutaneous injection of 1.2 mg/kg in healthy male subjects …
Phase 1 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC